Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices 11333 

Controlled substance Drug code Schedule 

Anileridine ........................................................................................................................................................................ 9020 II 

Diphenoxylate .................................................................................................................................................................. 9170 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine Intermediate-A .............................................................................................................................................. 9232 II 

Meperidine Intermediate-B .............................................................................................................................................. 9233 II 

Meperidine Intermediate-C .............................................................................................................................................. 9234 II 

Dextropropoxyphene ....................................................................................................................................................... 9273 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

The company plans to manufacture 

the above listed controlled substances as 

analytical reference materials, 

proficiency test materials and academic 

research materials for distribution to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021-03758 Filed 2-21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–790] 

Importer of Controlled Substances 

Application: Globyz Pharma, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Globyz Pharma, LLC has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 26, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 26, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on September 30, 2020, 

Globyz Pharma, LLC, 2101 Market 

Street, Suite 5, Upper Chichester, 

Pennsylvania 19061–4001, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled 

substance 

Drug 

code Schedule 

Oxycodone ..................... 9143 II 

The company plans to import the 

listed controlled substance to complete 

analytical testing. No other activity for 

these drug codes is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–03834 Filed 2–23–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Mine Safety and Health Administration 

Petitions for Modification of 

Application of Existing Mandatory 

Safety Standards 

AGENCY: Mine Safety and Health 

Administration, Labor. 

ACTION: Notice. 

SUMMARY: This notice is a summary of 

a petition for modification submitted to 

the Mine Safety and Health 

Administration (MSHA) by the party 

listed below. 

DATES: All comments on the petition 

must be received by MSHA’s Office of 

Standards, Regulations, and Variances 

on or before March 26, 2021. 

ADDRESSES: You may submit your 

comments, identified by ‘‘docket 

number’’ on the subject line, by any of 

the following methods: 

1. Electronic Mail: zzMSHAcomments@dol.gov. Include the docket 

number of the petition in the subject 

line of the message. 

2. Facsimile: 202–693–9441. 

3. Regular Mail or Hand Delivery: 

MSHA, Office of Standards, 

Regulations, and Variances, 201 12th 

Street South, Suite 4E401, Arlington, 

Virginia 22202–5452, Attention: S. 

Aromie Noe, Acting Deputy Director, 

Office of Standards, Regulations, and 

Variances. Persons delivering 

documents are required to check in at 

the receptionist’s desk in Suite 4E401. 

Individuals may inspect copies of the 

petition and comments during normal 

business hours at the address listed 

above. 

MSHA will consider only comments 

postmarked by the U.S. Postal Service or 

proof of delivery from another delivery 

service such as UPS or Federal Express 

on or before the deadline for comments. 


khammond on DSKJM1Z7X2PROD with NOTICES
11334 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices 

FOR FURTHER INFORMATION CONTACT: S. 

Aromie Noe, Office of Standards, 

Regulations, and Variances at 202–693– 

9440 (voice), noe.song-ae.a@dol.gov 

(email), or 202–693–9441 (facsimile). 

[These are not toll-free numbers.] 

SUPPLEMENTARY INFORMATION: Section 

101(c) of the Federal Mine Safety and 

Health Act of 1977 and Title 30 of the 

Code of Federal Regulations (CFR) part 

44 govern the application, processing, 

and disposition of petitions for 

modification. 

I. Background 

Section 101(c) of the Federal Mine 

Safety and Health Act of 1977 (Mine 

Act) allows the mine operator or 

representative of miners to file a 

petition to modify the application of any 

mandatory safety standard to a coal or 

other mine if the Secretary of Labor 

determines that: 

1. An alternative method of achieving 

the result of such standard exists which 

will at all times guarantee no less than 

the same measure of protection afforded 

the miners of such mine by such 

standard; or 

2. The application of such standard to 

such mine will result in a diminution of 

safety to the miners in such mine. 

In addition, the regulations at 30 CFR 

44.10 and 44.11 establish the 

requirements for filing petitions for 

modification. 

II. Petition for Modification 

Docket Number: M–2021–001–C. 

Petitioner: Patton Mining LLC., 12051 

9th Avenue Hillsboro Illinois (ZIP 

62049). 

Mine: Deer Run Mine, MSHA I.D. No. 

11–03182, located in Montgomery 

County, Illinois. 

Regulation Affected: 30 CFR 75.1909 

(Nonpermissible diesel-powered 

equipment; design and performance 

requirements). 30 CFR 75.1909(b)(6) 

requires self-propelled nonpermissible 

diesel-powered equipment to have 

service brakes that act on each wheel of 

the vehicle and that are designed such 

that failure of any single component, 

except the brake actuation pedal or 

other similar actuation device will not 

result in a complete loss of service 

breaking capacity. 

Modification Request: This petition is 

for a Getman Grader Model No. RDG– 

1504C, Serial No. 6718. The petitioner 

requests a modification of the existing 

standard to permit an alternative 

method of compliance in lieu of having 

front brakes for the Getman grader. 

The petitioner states that: 

(1) Road conditions in a coal mine 

tend to become very rough to travel on 

and can pose a serious hazard that 

exposes miners to an array of injuries. 

Road graders have proven to be the best 

type of mining equipment to maintain 

underground and surface roadways in 

the mining industry safe for travel. 

(2) The addition of front brakes could 

cause a loss of control if, for some 

unknown reason, one of the maintained 

brakes would lock up during operation. 

This could cause the grader to veer hard 

in one direction. Furthermore, the size, 

weight and location of the front brakes 

would put repair personnel in positions 

that could subject them to injury. 

As an alternative to the existing 

standard, the petitioner proposes the 

following: 

(a) No service brakes will be added to 

the front wheels of the Getman Grader 

Model No. RDG–1504C, Serial No. 6718 

in Deer Run Mine. In lieu of having 

front brakes, the grader will be 

maintained with 12.00 x 20.00 tires that 

will limit the speed of the grader to 10 

miles per hour. 

(b) The grader will not travel up or 

down the slope unassisted. If an 

instance arises that requires the grader 

to be taken out of the mine, an 

additional piece of equipment, with 

adequate braking capacity, will be 

utilized to assist in removing the grader 

out of the mine and returning it back 

into the mine, via the mine slope. 

(c) All grader operators will be trained 

to recognize appropriate levels of speed 

for the different road conditions. 

(d) All grader operators will be 

trained to lower the moldboard in 

emergency situations and prior to 

exiting the operator compartment. 

The petitioner asserts that the 

proposed alternative method will 

provide a level of safety equivalent to 

that provided by the existing standard. 

Song-ae Aromie Noe, 

Acting Deputy Director, Office of Standards, 

Regulations, and Variances. 

[FR Doc. 2021–03704 Filed 2–23–21; 8:45 am] 

BILLING CODE 4520–43–P 

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[21–011] 

Name of Information Collection: NASA 

Enterprise Salesforce COVID–19 

Contact Tracing 

AGENCY: National Aeronautics and 

Space Administration (NASA). 

ACTION: Notice of information collection. 

SUMMARY: The National Aeronautics and 

Space Administration, as part of its 

continuing effort to reduce paperwork 

and respondent burden, in compliance 

with the requirements of the Paperwork 

Reduction Act of 1995, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed and/or 

continuing information collections. 

DATES: Comments are due by March 26, 

2021. 

ADDRESSES: All comments should be 

addressed to Claire Little, National 

Aeronautics and Space Administration, 

300 E Street SW, Washington, DC 

20546–0001 or call 202–358–2375. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information or 

copies of the information collection 

instrument(s) and instructions should 

be directed to Claire Little, NASA 

Clearance Officer, NASA Headquarters, 

300 E Street SW, JF0000, Washington, 

DC 20546 or email claire.a.little@

nasa.gov. 

SUPPLEMENTARY INFORMATION: 

I. Abstract 

The information will be used to 

determine whether NASA personnel 

have been exposed to the COVID–19 

virus and to track and trace their 

interactions across the NASA 

community for identifying possible 

points of exposure. 

Those individuals that volunteer, will 

be contacted by a NASA Contact Tracer, 

a to-be-designated NASA healthcare 

employee, and will be first read the 

privacy act, to understand their rights 

and what this information will be used 

for. Then they will be asked, orally, to 

confirm if they have symptoms or not 

(yes/no question). The Tracer will then 

enter that information, as well as the 

names, phone numbers, and emails of 

those they have been in contact with 

into the newly developed tracking and 

tracing digital application on NASA’s 

enterprise solution, Salesforce. 

While participation is voluntary, it is 

strongly encouraged as failure to 

provide the requested information may 

result in potential increased exposure of 

personnel to the virus. 

NASA may share this information for 

authorized purposes with (1) private or 

other government health care providers 

or agencies for referral or special 

program responsibilities, and (2) other 

entities outlined under standard routine 

uses for all NASA systems of records. 

II. Methods of Collection 

The voluntary data is collected orally 

by a NASA Contact Tracer, a to-bedesignated NASA healthcare employee, 

who will then enter all the information 

into the newly developed tracking and 

tracing digital application on NASA’s 

enterprise solution, Salesforce. 


khammond on DSKJM1Z7X2PROD with NOTICES